Phyllodes Tumor as a Secondary Neoplasm in Survivors of Childhood Cancer: A Tertiary Care Cancer Centre Experience

J Pediatr Hematol Oncol. 2022 Jul 1;44(5):264-267. doi: 10.1097/MPH.0000000000002415. Epub 2022 Feb 4.

Abstract

Secondary neoplasms (SNs) are being increasingly identified in long-term survivors of childhood cancer. Phyllodes tumor (PT) form a distinctly uncommon SN. We report a series of 6 female childhood cancer survivors who developed PT as SN. The median age at primary diagnosis was 13 years. Their primary tumors were bone sarcoma (4) and acute leukemia (2), and all were treated with chemotherapy, predominantly with alkylating agents and/or anthracyclines. None had received direct radiotherapy to the chest wall. Subsequently, PT were detected after a median interval of 7.5 years, with 2 patients developing bilateral and malignant PT. The series highlights a rare SN in childhood cancer survivors, underscoring the importance of regular long-term follow-up.

MeSH terms

  • Bone Neoplasms* / therapy
  • Breast Neoplasms* / therapy
  • Cancer Survivors*
  • Child
  • Female
  • Humans
  • Leukemia, Myeloid, Acute*
  • Neoplasms, Second Primary* / etiology
  • Phyllodes Tumor* / etiology
  • Retrospective Studies
  • Tertiary Healthcare